Other studies have described that UBE2C, along with the other signaling molecules such as AURKA, EMT, GRIK3, CDK1, and claudin 19, activates the WNT/β-catenin signaling pathway, thus altering tumor biology [31]. The gene discussed is UBE2C; the disease is neoplasm.